PHARMA-ANESTH Flashcards

(555 cards)

1
Q

IF ARACHIDONIC ACID ENTERED THE CYCLOOXYGENASE PATHWAY, THE FOLLOWING BYPRODUCTS MAY BE PRODUCED, EXCEPT ONE. WHICH IS IT?

A

LEUKOTRIENES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

WHAT IS A SIDE EFFECT OF NITROUS OXIDE TOXICITY?

A

MYELONEUROPATHY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

WHAT ARE THE DIFFERENT TYPES OF CHANNEL BLOCKERS?

A

VERAPAMIL, NIFEDIPINE, AND DITIAZEM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

THIS DRUG IS BANNED DUE TO METHEMOGLOBIENMIA SIDE EFFECT?

A

PHENACETIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CLINDAMYCIN IS AN ANTIBIOTIC WHICH INHIBITS THE 50s RIBOSOMAL UNIT. HOWEVER, RECENT STUDIES FOUND OUT THAT THE ANTIBIOTIC ALSO ENHANCES ____ PROCESS BY WBC.

A

PHAGOCYTOSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SECONAL IS USED FOR WHICH OF THE FOLLOWING?

A

INSOMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

WHICH DRUG SHOULDN’T BE GIVEN TO PATIENTS WITH ASTHMA?

A

PROPRANOLOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SIMVASTATIN IS CLASSIFIED AS WHAT KIND OF DRUG?

A

ANTILIPID DRUG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A VERY IMPORTANT ENZYME THAT METABOLIZES AMIDE TYPE OF LOCAL ANESTHETICS

A

CP450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BEST USED WHEN DOING EXTRACTIONS FOR PATIENTS WITH LIVER DISEASE?

A

PROCAINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TERMINATION OF NITROUS OXIDE ADMINISTRATION, INHILATION OF 100% OXYGEN IS RECOMMENDED. THIS PROCESS WILL PREVENT _____?

A

DIFFUSION HYPOXIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PRICKLING, TINGLING, AND NUMBNESS ARE CLASSIC SIGNS OF _____________

A

PARESTHESIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IT REFERS TO THE PH OF A MEDIUM AT WHICH THE SUBSTANCES IS AT 50% IONIZED FORM AND 50% UNIONIZED FORM

A

pKa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DRUGS THAT ARE KNOWN TO POSSESS CROSS ALLERGENICITY TO PENICILLINS

A

CEPHALOSPORINS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DRUG THAT MAY DECREASE THE EFFECTIVENESS OF CLINDAMYCIN?

A

MACROLIDES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DIFFERENT GENERAL ANESTHETICS INHILATION AGENTS

A

SEVOFLURANE
DESFLURANE
NITROUS OXIDE
ISOFLURANE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

TREATMENT FOR MOTION SICKNESS

A

BONAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CO-TRIMOXAZOLE (BACTRIM) IS A COMBINATION OF?

A

TRIMETHOPRIN AND SULFAMETHOXAZOLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

WHICH ANDRENERGIC-RECEPTOR AGONIST IS USED FOR PATIENTS WITH ASTHMA?

A

BETA-2 RECEPTOR AGONIST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

THE MECHANISM OF ACTION OF NITRATES WHICH ALLOWS THEM TO TREAT ANGINA PECTORIS

A

VASODILATOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MANDIBULAR BLOCKING TECHNIQUE THAT IS USED FOR PATIENTS WITH LIMITED MOUTH OPENING

A

AKINOSI-VAZIRANI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

SULFONYLUREAS, BIGUANIDES AND THIAZOLIDINEDIONES ARE USED FOR____________?

A

DIABETES MELLITUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

THERE IS A PRECAUTION TO GIVE THIS KIND OF DRUG FOR PATIENTS WITH ASTHMA BECAUSE THEY MAY INDUCE BRONCHOSPASAM

A

MEFENAMIC ACID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

3 EXAMPLES OF ANTIFUGAL AGENTS

A

NYSTATIN, KETOCONOZOLE, ECONAZOLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
THE MECHANISM OF ACTION OF NSAIDs ARE _____________
THEY INHIBIT THE ACTION OF CYCLOOXYGENASE
26
WHICH OF THE FOLLOWINF CONDITIONS IS TREATED BY METHYLPHENIDATE (RITALIN)?
ADHD
27
EXAMPLES OF XANTHINE STIMULANTS
THEOPHYLLINE THEOBROMINE CAFFEINE NOTE: THOXANTHENE IS NOT XANTHINE STIMULANT
28
IT IS THE GENERATION OF CEPHALOSPORIN THAT PRIMARILY AFFECTS GRAM-POSITIVE BACTERIA
1ST
29
FOR AND ADULT PATIENT THE MAXIMUM DOSE OF LIDOCAINE WITH EPINEPHRINE IS _____ AND THE TOTAL DAILY DOSE MUST NOT GO BEYOND _____
7MG/KG AND 500 MG
30
IT IS RECOMMENDED MAXIMUM EPINEPHRINE CONCENTRATION ( FOR A 2CC CARTRIADGE) THAT CAN BE GIVEN TO PATIENTS WITH CARDIOVASCULAR DISEASE
1:50,000
31
IS THE GENERATION OF CEPHALOSPORIN THAT PRIMARILY AFFECTS GRAM-POSITIVE BACTERIA
1ST
32
A PATIENT WHO IS ALLERGIC TO LIDOCAINE SHOULDN'T BE GIVEN WHICH OF THE FOLLOWING LOCAL ANESTHETICS?
MEPIVACAINE
33
A PATIENT WITH STEROID-DEPENDENT ASTHMA WHO IS ALLERGIC TO SODIUM BISULFITE SHOULD BE GIVEN WHICH OF THE FOLLOWING LOCAL ANESTHETICS?
3% MEPIVACINE
34
IS A HIGHLY POISONOUS STIMULANT DRUG THAT IS COMMONLY USED AS A PESTICIDE
STYCHNINE
35
THERAPUTIC INDEX IS COMPUTED BY?
DIVIDING THE MEDIAL LETHAT DOSE OF THE DRUG (IN ANIMALS) TO THE MEDIAN EFFECTIVE DOSE OF THE DRUG (IN ANIMALS)
36
DETERMINE WHICH SENTENCE IS TRUE AND WHICH IS FALSE. COCAINE IS THE VERY FIRST LOCAL ANESTHESIA AND IT IS ALSO THE ONLY NATURALLY OCCURING. COCAINE AND TETRACAINE ARE BOTH VASOCONSTRICTORS.
THE FIRST STATEMENT IS TRUE WHILE THE SECOND ONE IS FALSE.
37
WHICH IS THE ANESTHETIC OF CHOICE FOR A PATIENT WITH CLINICAL HYPERTHYROIDISM?
3% MEPIVACAINE
38
IT IS AN ANTIGIBRINOLYTIC AGENT USED FOR PATIENTS WITH COAGULOPATHIES
AMINOCAPROIC ACID
39
WHICH IS CALSSIFIED AS A 3RD GENERATION CEPHALOSPORIN?
DEFOTAXIME
40
THIS IS THE SAFEST AMIDE LOCAL ANESTHETIC FOR PATIENTS WITH HEPATIC OF RENAL IMPAIRMENTS
articaine
41
CEFUROXIME, WHICH IS A CEPHALOSPORIN, IS INCLUDED IN WHAT GENERATION?
SECONDS
42
ALL ARE CLASSIFIED AS BETA-LACTAM ANTIBIOTICS.
PENICILLIN CEPHALOSPORIN MONOBACTAM CARBAPENEM
43
STATUS EPILEPTICUS IS BEST TREATED USING WHICH OF THE FOLLOWING ANTI-CONVULSANT?
DIAZEPAM
44
INSTRUCTION TO THE PATIENT WHICH MEANS "RECTALLY"
Pr
45
ANTIBIOTIC OF CHOICE FOR PATIENTS WITH AGGRESSIVE PERIODONTITIS
METRONIDAZOLE
46
IT REFERS TO THE AMOUNT OF MEDICATION TAKEN AT A SPECIFIC TIME
DOSE
47
PHYSOSTIGMINE AND NEOSTIGMINE ARE CLASSIFIED AS __________-
ANTICHOLINESTERASE
48
THE MOST COMMONLY USED VASOCONSTRICTOR IS?
ADRENALIN
49
SIDE EFFECT MOSTLY SEEN FREQUENTLY WITH ADMINISTRATION OF NITROUS OXIDE AND OXYGEN?
NAUSEA
50
AN ANTIBIOTIC KNOWN TO CAUSE APLASTIC ANEMIA
CHLORAMPHENICOL
51
ULTRA-SHORT ACTING BARBITURATES ARE COMMONLY USED FOR INDUCTION OF GENERAL ANESTHESIA BECAUSE IT RAPIDLY SKIPS___________ OF GUEDEL'S STAGES OF GENERAL ANESTHESIA
2ND STAGE
52
THIS IS THE MAXIMUM NUMBER IF EPINEOHRINE- CONTAINING CARTRIDGES THAT CAN BE GIVEN FOR CARDIO VASCULARCOMRPOMISED PATIENTS.
2CC OF 1:50,000 EPINEPHRINE
53
A LOCAL ANESTHESIA THAT IS 4x MORE POTENT THAT LIDOCAINE AND MEPIVACAINE, AND ALSO HAS A LONGER DURATION OF ACTION
BUPIVACAINE
54
HOW CAN EPINEPHRINE ANTAGONIZE THE LETHAL EFFECTS OF ANAPHYLAXIS?
PRODUCES PHYSIOLOGIC EFFECTS OPPOSITE TO HISTAMINE
55
BUFFERING THE LOCAL ANESTHESIA WITH _____ CAN MINIMIZE THE TYPICAL BURNING SENSATION DURING ADMINISTRATION OF THE LOCAL ANESTHESIA
NaHC03
56
PRIOR TO CEMENTING ORTHODONTIC MOLAR BANDS. ONE MAY USE THIS DRUG TO REDUCE SALIVATIOON. WHICH OF THESE DRUGS IS IT? CHLORAL HYDRATE? PILOCARPINE? ATROPINE? PYRIDOSTIGIMINE?
ATROPINE
57
WHICH IS THE ANESTHETIC OF CHOICE FOR A PATIENT WITH CARIOVASCULAR DISEASE?
3% MEPIVACAINE
58
THE MOSET COMMON CAUSE OF BACTERIAL RESISTANCE?
TAKING ANTBIOTICS WHEN NOT NEEDED
59
THIS IS THE MAXIMUM DOSAGE OF EPINEPHRINE THAT CAN BE GIVEN TO PATIENTS THAT HAVE CARIOVASCULAR DISEASE
0.04 MG
60
ANTIBIOTIC OF CHOICE FOR PATIENT WHO IS NOT ALLERGIC TO PENICILLIN AND HAS AN ODONTOGENIC INFECTION.
PENICILLIN
61
DENTIST ADMINISTER NITROUS OXIDE TO CALM THE CHILD, WHAT ARMAMENTARIUM WAS USED TO COVER THE NOSE OF THE PATIENT?
NASAL HOOD
62
GENERICS ACT OF 1998
RA 6675
63
AMONG THE FOLLOWING DRUGS, WHICH IS AN EXAMPLE OF AN NSAID? MIVACURIUM TERBUTALINE TRAMADOL NAPROXEN
NAPROXEN
64
ESTER LA ARE MORE COMMONLY ASSOCIATED TO ALLERGIES BECAUSE IT IS METABOLIZED INTO METHYLPARABEN. METHYLPARABEN IS COMMONLY USED AS A BACTERICIDAL AGENT. WHICH STATEMENTS ARE TRUE.
THE FIRST STATEMENT IS FALSE, THE SECOND IS TRUE
65
A DRUG THAT INDUCES GINGIVAL HYPERPLASIA
DIPHENYLHYDANTOIN
66
WHICH DRUG IS USED FOR XEROSTOMIA
PILOCARPINE
67
IT IS THE PROTOTYPE OF BETA BLOCKERS
PROPANOLOL
68
CONTRAINDICATED FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
NITROUS OXIDE
69
WHICH ANTIBIOTIC IS COMMONLY GIVEN INTRAMUSCULARLY TO TREAT BACTERIAL INFECTIONS
BEZATHINE PEN G
70
IT IS CONSIDERED AS THE SAFEST LOCAL ANESTHESIA, ESPECIALLY FOR PEDIATRIC PATIENTS
LIDOCAINE
71
IT IS A TYPE OF PAIN PRESENT DUE TO DYSFUNCTION OF THE PERIPHERAL OR THE CENTRAL NERVOUS SYSTEM, EVEN THERE IS ABSENCE OF NOCICEPTOR STIMULUS
NEUROGENIC
72
DIACETYLMORPHINE IS ALSO KNOWN AS
HEROIN
73
IN REMOVING MAXILLARY TORUS PALATINUS, WHICH OF THE FOLLOWING NERVE BLOCK SHOULD BE DONE?
INCISIVE AND GREATER PALATINE NERVE BLOCK
74
AMPHETAMINES IS CLASSIFIED AS WHAT KIND OF DRUG?
ANALEPTICS
75
CRUDE TOUCH, PAIN, AND TEMPERATURE IS PROCESSED IN WHAT PART OF THE BRAIN?
CEREBRAL CORTEX
76
IT IS THE AMOUNT OF DRUG NECESSARY TO PRODUCE MAXIMUM EFFECT
POTENCY
77
AMPHETAMINES IS CLASSIFIED AS WHAT KIND OF DRUG?
ANALEPTICS
78
IT MEANS IMMEDIATELY
STAT
79
THE COMMON LOCAL ANESTHETICS ASSOCIATED WITH PARESTHESIA ARE _________
ARTICAINE AND PRILOCAINE
80
PERIPHERAL NEUROPATHY IS SEEN IN PATIENTS GIVEN NITROUS OXIDE AND ISONIAZID. THIS IS DUE TO VITAMIN B12 DEFICIENCY WHICH STATEMENT IS TRUE
BOTH ARE TRUE
81
LIDOCAINE IS MORE WIDELY USED THAN PROCAINE IN ROUTINE DENTAL PRACTICE BECAUSE LIDOCAINE
CAUSES FEWER ALLERGIC REACTIONS
82
AFTER ADMINISTRATION OF 4 CARTRIDGES OF 2% LIDOCAINE WITH 1:100,000 EPINEPHRINE IN A 1.8ML. THE PATIENT RECEIVES HOW MANY MG OF EPINEPHRINE?
0.072 MG
83
MOST ACCEPTED WAY OF TREATING PATIENTS WITH TRISMUS AND ELEVATED BODY TEMPERATURE FROM ACUTE PERICORONITIS OF AN IMPACTED 3RD MOLAR
ANTIBIOTICS
84
THIS DRUG IS COMMONLY USED FOR PATIENTS WITH HYPERTHYRODISM
PROPYLTHIOURACIL
85
TARDIVE DYSKINESIA IS A COMMON SIDE EFFECT OF WHICH OF THE FOLLOWING DRUGS
ANTISPHYCHOTICS
86
IT IS A DRUG THAT MAY INCREASE THE RATE OF SALIVATION WHICH IS EFFECTIVE FOR PATIENTS WITH XEROSTOMIA
NEOSTIGMINE
87
WHICH OF THE FOLLOWING IS A DRUG USED FOR AMOEBIASIS
METRONIDAZOLE
88
HOW MANY MG OF MEPIVACAINE IS FOUND IN 3% MEPIVACAINE SOLUTION WITH VOLUME OF 2.0 CC
60MG
89
THIS IS A TYPE OF PENICILLIN THAT IS ALSO KNOWN AS ANTI-STAPHYLOCOCCAL PENICILLIN
PENICILLINASE-RESISTANT PENICILLIN
90
ALL ARE PARTS OF A PRESCRIPTION EXCEPT ONE SUPERSCRIPTION INSCRIPTION SUBSCRIPTION SIGNA SUPRASCRIPTION
SUPRASCRIPTION
91
GENERIC NAME OF LOCAL ANESTHESIA BRAND XYLOCAINE
LIDOCAINE
92
CARIDAC GLYCOSIDES ARE DRUGS THAT INCREASES THE FORCE OF CONTRACTION AND RATE OF CONTRACTION OF THE CARDIAC MYOCYTES. THIS HAPPENS BECAUSE THE DRUG REDUCES THE INTERCELLULAR CALCIUM OF THE CELLS. WHICH STATEMENT IS TRUE
THE FIRST STATEMENT IS TURE AND THE SECOND STATEMENT IS FALSE
93
OD MEANS
ONCE A DAY
94
IT REFERES TO THE ADMINISTRATION OF THE FREQUENCY, AMOUNT AND THE NUMBER OF DOSES TAKEN OVER A PARTICULAR PERIOD OF TIME
DOSAGE
95
TETRACYCLINE STAINS IS COMMONLY ASSOCIATED IN WHAT AGE GROUP?
<8,
96
THIS IS AN ANTI-MACROBIAL CONTENT OF LOCAL ANESTHETICS THAT ALSO CAUSES ALLERGIES TO PATIENTS
METHYLPARABEN
97
AFTER THE FIRST BREATH OF NITROUS OXIDE, IT ONLY TAKES TWENTY SECONDS TO REACH THE BRAIN AND ________ MINUTES AFTER IT WILL INHIBIT PAIN RECEPTORS
3 MINUTES
98
HOW MANY MG OF MEPIVACAINE WILL BE RECEIVED BY THE PATIENT IF YOU GIVE HIM 2 CARTRIDGES OF 3% MEPIVACAINE (1.8ML)
108 MG
99
A PATIENT WITH TONIC-CLONIC TYPE OF SEIZURE WOULD LIKELY BE TAKING WHICH OF THE FOLLOWING DRUGS?
PHENOBARBITAL
100
THIS IS THE ENZYME INHIBITED BY PYRIDOSTIGMINE
ACETYLCHOLINESTERASE
101
1ST SENSATION LOST AFTER ADMINISTRATION OF LOCAL ANESTHESIA
PAIN
102
WHICH IS THE ANESTHETIF OC CHOICE FOR A PATIENT WITH CLINICAL HYPERTHYROIDISM
3% MEPIVACAINE
103
PARADOXICAL EXCITEMENT IS SEEN IN WHICH OF THE FOLLOWING DRUGS
BENZODIAZEPINES
104
TERMINOLOGY OF PHARMA; DETERMINE THE FOLLOWING USING THEIR DEFINITION. -USES, EFFECTS, AND MODE OF ACTION OF A DRUG? -NATURAL RESOURCES -EFFECTS OF DRUG AND MECHANISM OF THEIR ACTION -MOVEMENT OF DRUGS -DRUM OF HARMMFUL EFFECTS -DAMAGE TO FETUS IN DEVELOPMENT -DRUG DOSAGE
PHARMACOLOGY PHARMOCOGNOSY PHARMACODYNAMICS PHARMACOKINETICS TOXICOLOGY TERATOLOGY POSPOLOGY
105
WHAT IS "ADME"
ABSORTION DISTRIBUTION METABOLISM EXCRETION
106
-MAIN SITE OF ABSORPTION IN THE BODY -PRIMARY SOLUBILITY OF DRUG TO BE ABSORBED / FORM OF DRUG THAT IS EASY TO ABSORB -IT IS RESPONSIBLE FOR METABOLISM -MAJOR SITE OF EXCRETION
JEJUNUM OF SMALL INTESTINE LIPID SOLUBLE FORM LIVER KIDNEY
107
-INDUCE VOMITING -DEPOSITION OF FLUID IN THE STOMACH THEN ASPIRATION OF LITTLE AMOUNTS -SIMILAR TO LAXATIVE - 1. LIVER DAMAGE 2. KIDNEY DAMAGE 3. CLEARANCE RATE DECREASES
SYRUP OF IPECAL GASTRIC LAVAGE CATHATICS CUMULATION IS ASSOCIATED WITH ORGAN DAMAGE
108
DRUG CONTRAINDICATED FOR GLAUCOMA
DIAZEPAM
109
EXAMPLES OF TERATOGENIC DRUGS
TETRACYCCLINE PHENYTOIN THALIDOMIDE
110
WHAT IS ABSORPTION? WHAT IS INTRAVENOUS? WHAT IS INTRADERMAL ROUTE?
-PROCESS OF DRUG UPTAKE FROM THE SITE OF ADMINISTRATION TOWARDS THE BLOODSTREAM -ROUTE WITH 100% BIOAVAILABILITY -PRODUCE LEAST AMOUNTS OF DRUG ABSORPTION
111
-MOST COMMON SITE IV ADMINISTRATION -MOST COMMON MUSCLE USED IN ADMINISTRATION -FASTEST ROUTE IF THE TARGET SITE IS THE BRAIN (SEDATION) -MOST COMMON DRUG AMDINISTERED SUBCUTAENUSLY
ANTECUBITAL REGION VASTUS LATERALIS INHALATION INSULIN
112
-ROUTE BYPASSES MEMBRANE -ROUTE BYPASSES ABSORPTION PROCESS -WHAT ARE THE PROPERTIES THAT INFLUENCE ABSORPTION
INTRAVENOUS INTRAVENOUS IV -MUST BE WEAK ACIDS (PH OF 6) OR WEAK BASES (PH OF 8) -WEAK ACIDS ARE ATTRACTED TO ANOTHER PH LEVEL (6-7.4) -WEAK BASES ARE ATTRACTED TO ANOTHER PH LEVEL (8-7.4)
113
-OTHER MUSCLE THAT CAN BE USED IN "IM" ADMINISTRATION -WHAT IS VERY HYDROPHILIC WATER SOLUBLE -WHAT IS VERY VERY HYDROPHILIC WATER SOLUABLE -WHAT IS LIPID SOLUABLE
GLUTEUS MAXIMUS AND DELTOID DRUG SOLUBILITY THAT IS UNABLE TO CROSS THE PHOSPHOLIPID BILAYER SOLUBILITY OF DRUG THAT IS UNABLE TO BE ABSORBED DUE TO INSOLUBILITY IN AQUEOUS FLUID PRIMARY SOLUBILITY OF DRUG TO BE ABSORBED
114
GIVE THE TERMS OF LIPID SOLUBLE GIVE THE TERM OF WATER SOLUBLE FORM
-UNIONIZED FORM -FAT SOLUBLE FORM -WATER-INSOLUBLE FORM -HYDROPHOBIC DRUG FORM -IONIZED FORM HYDROPHILIC FAT- INSOLUBLE LIPID-SOLUBLE
115
ROUTE OF ADMINISTRATION: WHERE IS THIS ADMINISTERED? ENTERAL? PARENTERAL? GIVE THE DEGREE OF EACH ANSWER
ORAL AND RECTAL INTRAVENOUS IV 35 INTRAMASCULAR IM 90 INTRDERMAL ID 0 TO 15 SUBCUTANEOUS 45
116
AMOUNT OF DRUG THAT REACHES THE CIRCULAROTY SYSTEM AFTER ADMINISTRATION
BIO AVAILABILITY
117
BIOAVAILABILITY IS INFLUENCED BY? ABILITY OF DRUG TO MOVE FROM CIRCULATORY SYSTEM INTO THEIR TARGET SITES
DRUG SOLUBILITY ROUTE OF ADMINISTRATION FIRST-PASS EFFECT DISTRIBUTION
118
FREE FLOATING DRUG IN THE PLASMA FLUID ATTACHED TO PLASMA PROTEINS / BOUNDED TO ALBUMIN
FREE IONIZED DRUG BOUND DRUG
119
2 COMMON PROTEIN WHERE THE DRUG ATTACHES TO (BIND)
ALBUMIN ALPHA 1 ACID GLYCOPROTEIN
120
-TENDENCY OF A SUBSTANCE TO SEPARATE OR DISSOCIATE FROM ITS BINDING -TEMPORARY STORAGE OF DRUGS -DRUG CAN METABOLIZE IN SEVERAL PARTS OF THE BODY
DISSOCIATION CONSTANT (KD) BLOOD PLASMA FAT ADIPOCYTES
121
-PRIMARY ORGAN RESPONSIBLE FOR DRUG METABOLISM -MOST IMPORTANT MICROSOMAL ENZYME OF LIVER
LIVER CYTOCHROME P450
122
WHAT ARE THE LIVER FUNCTIONS
CONVERTS LIPID SOLUABLE DRUGS TO LIPID INSOLUABLE DRUGS CONVERTS ACTIVE DRUG TO INACTIVE FORM CONVERTS PRODRUG TO ACTIVE FORM
123
EXAMPLES OF PRODRUGS DRUGS METABOLIZED BY THE LIVER DRUG METABOLIZED BY PLASMA
ASPIRIN CODEINE LEVODOPIN LEVOTHYROXINE ALCOHOL MOST DRUG / AMIDE ESTER SUCCINYLCHOLINE
124
-EZNYME USED BY PLASMA -MOST COMMON TOPICAL ANESTHESIA
PLASMA PSEUDOCHOLINESTERASE BENZOCAINE
125
WHAT IS EPAL? AMIDE BUT BOTH METABOLIZED IN BOTH LIVER AND PLASMA "LA" USED IF ALLERGIC TO BOTH ESTER AND AMIDE
ESTER-PLASMA-AMIDE-LIVER ARTICAINE DIPHENHYDRAMINE (BENADRYL)
126
PRIMARY USED TO SUCCINYLCHOLINE DRUG EXCRETED BY THE LUNGS SUBSTANCES EXCRETED BY THE SUSU (BREAST MILK)
LARYNGOSPASM NITROUS OXIDE ALCOHOL, CAFFEINE, COCAINE, NICOTINE
127
TIME REQUIRED FOR A DRUG TO REDUCE HALF OF ITS INITIAL VALUE RATE AT WHICH THE ACTIVE DRUG REMOVED A CERTAIN DOSE ELIMINATED PER CERTAIN AMOUNT OF TIME
HALF LIFE (T1/2) CLEARANCE RATE
128
WHAT IS ZERO ORDER KINETICS WHAT IS FIRST ORDER KINETICS
AMOUNT OF DRUG ELIMINATED IS CONSTANT AND IS NOT DEPENDENT ON THE CONCENTRATION OF DRUG IN PLASMA FLUID AMOUNT OF DRUG ELIMINATED IS DEPENDENT ON THE CONCENTRATION OF DRUG IN PLSAMA FLUID
129
EFFECTS OF DRUGS AND MECHANISMS OF ACTION
PHARMACODYNAMICS
130
DOSAGE OF A DRUG NEEDED TO PRODUCE AN EFFECT
POTENCY
131
MORE DOSE NEEDED___POTENT DRUG
LESS
132
LESSER DOSE NEEDED____ POTENT DRUG
MORE
133
EFFECT OF A DRUG
EFFICACY
134
HIGHER EFFICACY(DRUG)____EFFICATION
MORE/HIGHER
135
INCREASE DOSE- INCREASE EFFECT UNTIL ___ IS REACHED
MAXIMAL EFFECT
136
IT REFERS TO HOW WELL THE DRUG CAN BE USED IN REAL WORLD
EFFECTIVENESS
137
2 TYPES OF DOSE RESPONSE CURVE
GRADED DOSE EFFECT CURVE QUANTAL DOSE EFFECT CURVE
138
CURVE THAT DESCRIBE THE DEGREE RESPONSE OF A SINGLE BIOLOGICAL UNIT (CELL OR HUMAN) TO A GUVEN DOSE.
GRADED DOSE EFFECT CURVE
139
Y-AXIS X-AXIS
EFFECT DOSE
140
CURVE THAT DESCRIBE RELATIONSHIP BETWEEN THE INCREASING DRUG DOSAGE AND THE PERCENTAGE OF POPULATION THAT SHOWS THE DRUGS PHARMACOLOGICAL AND LETHAL EFFECTS
QUANTAL DOSE EFFECT CURVE
141
Y-AXIS X-AXIS
POPULATION DOSE
142
CURVE THAT DETECTS THE "MARGIN OF SAFETY" OF A DRUG BY COMPARING THE THERAPEUTIC DOSE AND TOXIC DOSE.
QUANTAL DOSE EFFECT CURVE
143
FORMULA OF THERAPEUTIC INDEX
TI=LD50/ED50 (TLE)
144
RATIO THAT MEASURES THAT RELATIVELY SAFETY OF A DRUG
THERAPEUTIC INDEX
145
MEDIAN LETHAL DOSE / DOSE THAT MAY POSSIBLY KILL HALF OF POPULATION.
LD50
146
MEDIAN EFFECTIVE DOSE/DOSE OF DRUG THAT HAS THERAPEUTIC EFFECT IN 50%
ED50
147
MEDIAL TOXIC DOSE
TD50
148
HIGHER THERAPEUTIC INDEX THE ___ THE DRUG
SAFER
149
LOWER THERAPEUTIC INDEX THE ___HARMFUL THE DRUG
MORE
150
DRUG THAT HAS NARROW THERAPEUTIC INDEX
CHEMOTHERAPEUTIC AGENTS DIGOXINE
151
TARGETS OF DRUG ACTION
RECEPTORS ENZYMES DRUGS ACTING PHYSICAL OR CHEMICAL AGENTS
152
DRUG WITH RECEPTORS AS TARGET SITES:
NARCOTIC CHOLINERGIC DRUGS
153
RECEPTOR SITE OF NARCOTIC AGENTS
MU KAPPA DELTA
154
DRUGS WITH ENZYMES AS TARGET SITES:
MAO INHIBITOR ANTI-ACETYLCHOLINESTERASE OR ANTICHOLINESTERASE
155
ANTI-ACETYLCHOLINESTERASE OR ANTICHOLINESTERASE IS USED IN DISEASE CALLED
MYASTHENIA GRAVIS (MUSCLE WEKANESS) -TO IMPROVE MASCULAR CONTRACT.
156
ABILITY OF DRUG TO BIND ITS TARGET SITE.
AFFINITY
157
ABILITY OF DRUG TO PRODUCE AN EFFECT AFTER BINDING TO ITS TARGET SITE.
INTRINSIC ACTIVITY
158
MAXIMAL RESPONSE BY ACTIVATING ALL RECEPTOR SITE.
FULL AGONIST
159
PRODUCE LESS MAXIMAL RESPONSE EVEN ALL RECEPTOR ARE OCCUPIED.
PARTIAL AGONIST
160
FULL AND PARTIAL AGONIST
AGONIST
161
DRUG BINDS TO RECEPTOR SITE BUT IT DOESNT CREATE ANY EFFECTS ON THE RECEPTOR
ANTAGONIST
162
COMPETES WITH RECEPTORS SITE HERE IN OUR BODY SPECIFICALLY WITH THE MUSCARINIC RECEPTOR
BELLADONNA ALKALOIDS
163
OLD TERM OF SCOPALAMINE
HYOSCINE BUTYLBROMIDE "BUSCOPAN"
164
USED TO ABDOMINAL CRAMPS/ FOR HYPERACIDITY
SCOPALAMINE
165
ANTAGONIST OF NARCOTIC DRUG
NALOXONE OR NALTREXONE
166
ANTAGONIST OF BENZODIAPZEPINES (DIAZEPAM)
FLUMAZENIL
167
DRUGS THAT ACTS AS PHYSICAL OR CHEMICAL AGENTS
EPINEPHRINE INSULIN
168
PART OF THE BODY WHERE DRUGS INTERACT TO PRODUCE THEIR EFFECTS.
RECEPTORS
169
ACH (ACETYCHOLINE) IS?
AGONIST
170
ANTICHOLINERGIC DRUGS IS?
ANTAGONIST
171
ANTICHOLINERGIC DRUGS: BELLADONNA ALKALOIDS
SCOPALAMINE ATROPINE
172
TYPE OF ANTAGONIST THAT COMPETES WITH RECEPTOR OF AGONIST / RESULT TO DECREASE POTENCY
COMPETITIVE ANTAGONISTS
173
TYPE OF ANTAGONIST THAT HAS ITS OWN RECEPTORS; DOESNT COMPETE / RESULT DECREASE EFFICACY
NON COMPETITIVE ANTAGONIST
174
MOST ACCEPTED THEORY
CLARKS "OCCUPATIONAL THEORY"
175
DRUG EFFECT IS PROPORTIONAL TO THE NUMBER OF RECEPTORS OCCUPIED.
CLARK'S OCCUPATIONAL THEORY
176
HAS AFFINITY AND INTRINSIC ACTIVITY
FULL AGONIST
177
HAS AFFINITY BUT NO INTRINSIC ACTIVITY
ANTAGONIST
178
HAS AFFINITY BUT LESSER INTRINSIC ACTIVITY COMPRED TO AGONIST
PARTIAL AGONIST
179
DRUG EFFECT ID PROPORTIONAL TO THE RATE AT WHICH THE DRUG AND RECEPTOR COMBINE
PATON'S RATE THEORY
180
DRUG AS ASSOCIATES QUICKLY AND DISSOCIATES IMMEDIATELY TO THE RECEPTOR.
AGONISTS
181
DRUG IS ASSOCIATES BUT DISSOCIATES MUCH SLOWER/REASSOCIATION TO THE RECEPTOR IS ALSO SLOWER
ANTAGONIST
182
DRUG THAT CAN INDUCED SEDATION OR HYPNOSIS
SEDATIVE HYPNOTICS
183
SEDATIVE HYPNOTICS ARE DRUG THAT USED FOR:
SEDATION HYPNOSIS MUSCLES RELAXATION
184
DRUG THAT HAS ANTI-ANXIETY EFFECT/CALMING EFFECT
SEDATION
185
INDUCE DROWSINESS/ENCOURAGE SLEEP MUSCLE RELAXATION
HYPNOSIS
186
FEELING ASLEEP; LOSS OF ANXIETY
SEDATION
187
TYPE OF SEDATION THAT AWAKE AND RELAX
MINIMAL (CONSCIOUS)
188
TYPE OF SEDATION THAT DEPRESSED CONSCIOUSNESS; PX CAN STILL RESPOND TO EXTERNAL STIMULI
MODERATE
189
TYPE OF SEDATION THAT DEPRESSED CONSCIOUSNESS; PX RESPONDS TO PAINFUL OR REPEATED STIMULI
DEEP
190
MEDICALLY INDUCED COMA
GENERAL ANESTHESIA
191
CLASSIFICATION OF SEDATIVE HYPNOTICS (2)
BARBITURATES AND NON-BARBITURATES
192
ACTIVE INGREDIENT OF BARBITURATES THAT PRODUCES SEDATIVE EFFECT
BARBARIC ACID
193
BARBITURATE USED TO INDUCE GENERAL ANESTHESIA
ULTRA SHORT ACTING
194
VERY SHORT DURATION OF ACTION FAST INDUCTION BECAUSE LIPID SOLUBLE , RAPID RECOVERY
ULTRA SHORT ACTING
195
DRUGS OF ULTRA SHORT ACTING
THIOPENTAL AND METHOHEXITAL
196
SHORT ACTING (SPENT)
SECOBARBITAL AND PENTOBARBITAL
197
INTERMEDIATE ACTING (AMBUT)
AMOBARBITAL AND BUTABARBITAL
198
LONG ACTING
PHENOBARBITAL MEPHOBARBITAL AND PRIMIDONE
199
TYPE OF BARBITURATES THAT USED FOR INSOMNIA
SHORT & INTERMEDIATE ACTING
200
TYPE OF BARBITURATE USED FOR EPILEPTIC SEIZURE
LONG ACTING
201
END OF STAGE 1 AND START OF STAGE 2 OF GENERAL ANESTHESIA
UNCONSCIOUS PATIENT
202
STAGE OF AMNESIA AND ANALGESIA
STAGE 1
203
CANNOT CREATE NEW MEMORIES
ANTEROGRADE
204
LOST OF OLD/PAST MEMORIES
RETROGRADE
205
UNSTABLE STAGE OF GENERAL ANESTHESIA
STAGE 2
206
DRUG THAT MAINTAIN THE DOSE OF GENERAL ANESTHESIA
LONG ACTING BARBITURATES
206
THIS STAGE WANT TO SKIP OF ANESTHESIOLOGIST
STAGE 2
206
STAGE 3
SURGICAL STAGE
207
RAPID DISTRIBUTION FROM BRAIN TO OTHER TISSUE
STAGE 4
207
STAGE 2
DELIRIUM AND EXCITEMENT
207
CALLED DESIRABLE STAGE MAINTAIN DOSE/STABLE STAGE
STAGE 3
208
STAGE 4
MEDULLARY PARALYSIS AND RESPIRATORY DEPRESSION
209
STAGE 1-4 OF GENERAL ANESTHESIA BY?
GUEDEL'S STAGE OF GENERAL ANESTHESIA
209
SEDATIVE HYPNOTICS THAT NO BARBARIC ACID
NON-BARBITURATES
209
COMMONLY USED "NON-BARBITURATE" IN PX.
CHLORAL HYDRATE
209
REGULATES SLEEP-WAKE CYCLE IN SEDATIVE HYPNOTICS CAN AFFECT?
RETICULAR ACTIVATING SYSTEM (RAS)
209
COMMON SEDATIVE DRUG USED IN PEDIATRIC
CHLORAL HYDRATE
209
NON-BARBITURATE FOR INSOMNIA
FLUMAZEPAM
209
COMMON SEDATIVE DRUG USED IN DENTISTRY
MIDAZOLAM (BENZODIAZEPINES)
209
ANXIOLYTIC DRUG
BUSPIRONE
210
USED AS LOCAL ANESTHESIA WHEN PATIENT IS ALLERGIC BOTH ESTER AND AMIDE
DIPHENHYDRAMINE
210
NON-BARBITURATE FOUND IN ALCOHOL
ETHANOL
210
DRUG USED FOR INSOMNIA (NON-BARBITURATE)
RAMELTEON ESZOPICLONE ZOLPIDEM ZALEPLON
210
ANXIOLYTIC SEDATIVE EFFECT BUT THE PRIMARY IS ALSO AN ANTI-HISTAMINE
DIPHENHYDRAMINE
211
MOST COMMON INHIBITORY NEUROTRANSMITTER
GABA RECEPTOR
212
SEDATIVE VS GABA
SEDATIVE ENHANCES GABA
213
DRUG COMPONENTS OF LETHAL INJECTION
THIOPENTAL PANCURONIUM BROMIDE POTASSIUM CHLORIDE
214
SEDATIVE HYPNOTICS DRUG USED:
SEDATION INDUCTION OF G.A INSOMNIA ANTI-SEIZURE AND ANTI-ANXIETY
215
3 SLEEP AROUSAL STATE
AWAKE ASLEEP DREAMING
216
ADVERSE EFFECT OF SEDATIVE HYPNOTIC
DRUG DEPENDENCE STIMULATES PORPHYRIN PRODUCTION RESPIRATORY DEPRESSION COMA
217
ANY DRUG AFFECT CNS THEY CAUSED ADDICTION. TRUE OR FALSE
TRUE
218
RED-ELEVATED PPORPHYRIN
PORPHYRISM
219
LEAD TO DEATH
RESPIRATORY DEPRESSION
220
DRUG INTERACTION OF SEDATIVE HYPNOTIC
*INCREASE OF LIVER MICROSOMAL ENZYME *INCREASE ACTIVITY OF COUMARIN-RELATED AGENTS *PRECAUTION TO COMBINE WITH OTHER CNS DEPRESSANT
221
CNS DEPRESSANT DRUGS (SNAB)
SEDATIVE NARCOTIC ALCOHOL BENZODIAZEPINES
222
SEDATIVE HYPNOTICS DRUG PRECAUTION TO COMBINE WITH OTHER CNS DEPRESSANT BECAUSE?
SYNERGISTIC EFFECT
223
1+1+=>2
SYNERGISTIC
224
1+1=2
ADDITIVE
225
1+1=0
ANTAGONIST
226
1+0=2
POTENTIATION
227
SEDATIVE HYPNOTICS PRODUCE ANALGESIA. TRUE OR FALSE?
FALSE, BECAUSE IT IS NOT PRODUCE ANALGESIA. IT PRODUS DRUG DEPENDENCE
228
ANTICONVULSANTS IS AKA:
ANTISEIZURE,ANXIOLYTIC,ANTI-ANXIETY,MINOR TRANQUILIZERS
229
PRIMARY USE OF ANTICONVULSANT DRUG
ANTI-EPILEPTIC OR ANTI-SEIZURE,ANTI-ANXIETY
230
TYPES OF SEIZURE (2)
PARTIAL SEIZURE GENERALIZED SEIZURE
231
ABNORMAL ACTIVITY IN JUST ONE PART OF BRAIN
PARTIAL SEIZURE
232
ABNORMAL ACTIVITY IN ALL PART OF BRAIN
GENERALIZED SEIZURE
233
AKA PETITMAL SEIZURE/ BLANKING OUT
ABSENCE SEIZURE
234
ABSENCE OF MOVEMENT FOR FEW SECONDS
ABSENCE SEIZURES
235
AWAKE; SHOCK-LIKE JERKS OF A SINGLE OR GROUP OF MUSCLEM(MUSCLES ARE JERKINGS)
MYOCLONIC
236
"DROP SEIZURE"
ATONIC SEIZURE
237
ABSENCE OF MUSCLE TONE; AWAKE; MUSCLE RELAXATION FOR FEW SECONDS TO FEW MIN.
ATONIC SEIZURE
238
MOST COMMON TYPE OF GENERALIZED SIZURE
TONIC CLONIC SEIZURE
239
"GRANDMAL SEIZURE"
TONIC CLONIC SEIZURE
240
STIFFED MUSCLES INITIALLY (MUSCLES STIFFNESS+JERKING MOVEMENTS)
TONIC CLONIC SEIZURE
241
REPEATED GRANDMAL
STATUS EPILEPTICUS
242
DOC FOR TONIC CLONIC SEIZURE & STATUS EPILEPTICUS
DIAZEPAM (BENZODIAPINES) PHENYTOIN
243
SEVERE TYPE OF TONIC CLONIC SEIZURE
STATUS EPILEPTICUS
244
COMMON DRUGS ANTI-SEIZURE
BENZODIAPINES PHENYTOIN CARBAMAZEPINES VALPORIC ACID BARBITURATES
245
CHEMICAL NAME OF PHENYTOIN
DIPHENYLHYDANTOIN
246
BRAND NAME OF PHENYTOIN
DILANTIN SODIUM
247
DRUG ASSOCIATED WITH GINGIVAL HYPERPLASIA
PHENYTOIN CYCLOSPORINE CALCIUM CHANNEL BLOCKER
248
CALCIUM CHANNEL BLOCKER DRUG DRUGS:
NIFEDIPINE AMLODIPINE VERAPAMIL
249
BRAND NAME OF CARBAMAZEPINE
TEGRETOL
250
DOC FOR TIC DOULOUREUX (PAINFUL SPAMS)
CARBAMAZEPINE
251
DOC FOR TRIGEMMINAL NEURALGIA
CARBAMAZEPINE
252
LOCAL ANESTHESIA USED FOR TRIGEMINAL NEURALGIA
BUPIVACAINE
253
MAINLY "SEDATIVE HYPNOTIC"
BARBITURATES (LEAST)
254
MECHANISMS ACTION OF ANTI-SEIZURE DRUG
ACTIVATES GABA RECEPTOR INCREASE INHIBITION OF THE DIFFERENT PARTS OF CNS(NEUROTRANSMITTER)
255
DRUG USES OF ANTICONVULSANT OR ANTI-SEIZURE
ANTI-ANXIETY INDUCTION OF G.A INSOMNIA
256
ANTICONVULSANT USED TO INDUCE GENERAL ANESTHESIA (MOST COMMON)
BENZODIAPZEPINE (MIDAZOLAM)
257
OTHER ADVERSE EFFECT OF ANTICONVULSANTS
SEVERE SEDATION PARADOXIMAL EXCITEMENT ANTI-ANXIETY DRUG DEPENDENCE RESPIRATORY DEPRESSION INDUCE GINGIVAL HYPERPLASIA (PHENYTOIN)
258
ANTI-SEIZURE + ANTI-ARRYTHMIC DRUG
PHENYTOIN
259
BENZODIAZEPINES ARE METABOLIZED SLOWLY BY THE:
LIVER
260
ACTIVE METABOLITE OF BENZODIAZEPINE
DIMETHYLDIAZEPAM
261
IS SLOWLY AND POORLY ABSORBED IN ROUTE OF IV ADMINISTRATION
DIAZEPAM (ORAL AND IV)
262
MOST COMMON ADVERSE EFFECT OF ANTICONVULSANT
SEVERE SEDATION
263
ASSOCIATED WITH BENZODIAZEPINES NITROUS OXIDE "LAUGHING GAS" STAGE OF PHARMACOKINETICS
PARADOXIMAL EXCITEMENT(THAT BY PASS: METABOLISM STAGE)
264
CNS DEPRESSANT AGENT WHEN COMBINE TO ANTICONVULSANT THEY PRODUCE?
SYNERGISTIC DRUG INTERACTION
265
DRUG WITH SLIGHT ANTI-CHOLINERGIC EFFECTS (DiTRiBeAM)
DIPHENHYDRAMINE TRICYCLIC ANTIDEPRESSANT BENZODIAZEPINE ANTIPSYCHOTIC MEPERIDINE
266
PREACUTION TO GIVE TO A PX WITH GLAUCOMA
DIPHENHYDRAMINE TRICYCLIC ANTIDEPRESSANT BENZODIAZEPINE ANTIPSYCHOTIC AGENTS MEPERIDINE ATROPINE & SCOPALAMINE
267
NARCOTIC AND NON-NARCOTIC
ANALGESIC
268
GOLD STANDARD OF NARCOTICS
MORPHINE
269
NARCOTIC DERIVED FROM PLANT
POPPY PLANT (PAPAVER SOMNIFERUM)
270
AKA NARCOTIC THAT ON OPIOIDS RECEPTOR (3O'S)
OPIOIDS OPIUM OPIATES
271
3 RECEPTOR OF NARCOTIC RECEPTOR
MU KAPPA DELTA
272
DRUGS WITH MORPHINE-LIKE PROPERTIES THAT ACT IN CNS
MORPHINE
273
MECHANISM ACTION OF NARCOTIC (MU,KAPPA,DELTA) FOUND IN:
1. LIMBIC SYSTEM - EMOTION CENTER OF BRAIN *HIPPOCAMPUS- MEMORY CENTER *AMYGDALA-RESPONSIBLE FOR FEAR,ANGER,AROUSAL (ALMOND SHAPE) *SUBSTANSTIA NIGRA- DOPAMINE PRODUCTION *BASAL GANGLIA- VOLUNTARY MOTOR MOVEMENTS 2. AREA POSTREMA 3. SOLITARY NUCLEI 4. SUBSTANSTIA GELATINOSA OF ROLANDO
274
STRUCTURE FOUND IN "MEDULLA OBLONGATA"
AREA POSTREMA SOLITARY NUCLEI
275
RESPONSIBLE FOR NAUSEA AND VOMITING
AREA POSTREMA
276
RESPONSIBLE FOR GAG REFLEX, COUGH REFLEX, BARORECEPTOR, GASTRIC MOTILITY
SOLITARY NUCLEI
277
NARCOTICS THAT SUPPRESSES COUGH REFLEX
ANTI-TUSSIVE DRUG
278
EXAMPLE DRUG OF ANTI-TUSSIVE DRUG
DEXTROMETHORPIN (ROBITUSSIN)
279
HAS ANTI-DIARRHEA EFFECT DRUG TAKEN TO INHIBIT GASTRIC MOTILITY
LOPERAMIDE (DIATABS)
280
DESCRIBE "GATE" IN GATE CONTROL THEORY
SUBSTANSTIA GELATINOSA OF ROLANDO
281
MOST ACCEPTED THEORY FOR PAIN
GATE CONTROL THEORY
282
PAIN STIMULUS IT __ GATE NON-PAINFUL STIMULUS IT __ GATE
OPEN CLOSE
283
GATE CONTROL THEORY PROPOSED BY:
MELZACH & WALL
284
ENDOGENOUS OPIOIDS PRODUCED BY OUR BODY
ENCEPHALINS & ENDORPHINS
285
NARCOTIC BLOCK PAIN IN THE PNS. TRUE OR FALSE?
FALSE, IT BLOCKS THE CNS ONLY
286
COMBINATION OF DIPHENOXYLATE AND ATROPINE
LOMOTIL (BISACODYL)
287
THERAPEUTIC EFFECT OF NARCOTICS
ANALGESIA SEDATION EUPHORIA (DYSPHORIA) ELIMINATES COUGH DRUG DEPENDENCE NAUSEA RESPIRATORY DEPRESSION
288
WHAT KIND OF DRUG IS GUAIFENESIN
EXPECTORANT
289
OVERDOSE OF MORPHINE (CHARACTERISTIC OF MORPHINE TRIAD)
PIN-POINT PUPIL (MIOSIS) COMA RESPIRATORY DEPRESSION
290
COMPONENTS OF NEUROLEPTIC ANALGESIA (ANESTHETIC TECHNIQUE THAT PUTS PX IN STAGE 1 (AMNESIA&ANALGESIA)
NARCOTIC AGENTS NEUROLEPTIC AGENTS NITROUS OXIDE
291
ALSO CALLED HALLUCINOGEN/ANTI-PSYCHOTIC/MINOR TRANQUILIZER
NEUROLEPTIC AGENTS
292
INDUCE HALLUCINATIONS (NEUROLEPTIC FRUG)
BUTYROPHENONES (DROPPERIDOL)
293
DRUG THAT CAUSES DISSOCIATIVE ANESTHESIA
KETAMINE
294
DESCRIBE AS TRANCE-LIKE STATE
DISSOCIATIVE ANESTHESIA
295
THE PX LOOKS AWAKE BUT PX IS UNCONSCIOUS
DISSOCIATIVE ANESTHESIA
296
TYPE OF NARCOTIC DRUG CONTRAINDICATED TO GLAUCOMA
MEPERIDINE
297
CONTRAINDICATED TO GLAUCOMA (DiTRIBeAM)
DIPHENHYDRAMINE TRICYCLIC ANTIDEPRESSANT BENZODIAZEPINES ANTIPSYCHOTIC DRUG MEPERIDINE * BECAUSE IT HAS A SLIGHT CHOLINERGIC DRUG
298
DRUG USED FOR SEVERE OROFACIAL PAIN
CODEINE
299
PRODRUG CONVERTED TO MORPHINE
CODEINE
300
CODEINE COMMON USED IN DENTAL BECAUSE:
IT HAS LOW DRUG DEPENDENCE
301
ACETAMINOPHEN IS SIMILAR WITH DRUG IN PH
PARACETAMOL
302
OTHER TERM OF ACETAMINOPHEN
A-PARAMINOPHENOL OR N-ACETYL PARAMINOPHENOL
303
OXYCODONE + ACETAMINOPHEN=
TYLOX (SYNERGISTIC EFFECT)
304
PERCOCET
OXYCODONE
305
MOLLY
ECSTASY (PARTY DRUG)
306
ROUTE OF ADMINISTRATION OF MORPHINE AND MEPERIDINE
PARENTERAL (IV)
307
CODEINE,OXYCODONE,METHADONE ADMINISTERED:
ORALLY
308
MORE POTENT THAN MORPHINE
FENTANYL
309
DIACETYLMORPHINE
HEROIN
310
BIG H HORSE BROWN SUGAR
HEROIN
311
STREET NAME: COCAINE
COKE / CANDY
312
POOR MAN'S COCAINE SHABU CRYSTAL METH
METHAMPETAMINE
313
DENTAL DISEASE ASSOCIATED WITH METHAMPHETAMINE HCL IS:
METH MOUTH
314
MJ BLUNT WEED
MARIJUANA (CANNABIS SATIVA)
315
DRUG THAT SHOULDN'T BE COMBINED WITH MAO INHIBITORS
MEPERIDINE
316
MEPERIDINE SHOULD NOT COMBINE TO MAO INHIBITOR BECAUSE
IT WILL PRODUCE HYPERPYREXIA
317
OTHER DRUGS CONTRAINDICATED FOR MAO INHIBITOR ARE:
SSRI EPHEDRINE EPINEPHRINEEE
318
REVERSAL AGENT FOR NARCOTIC TOXICITY
NALOXONE OR NALTREXONE
319
DRUGS THAT ARE ASSOCIATED WITH RESPIRATORY DEPRESSION AND DRUG DEPENDENCE
SEDATIVE SEDATION NARCOTICS ALCOHOL BENZODIAZEPINES
320
NON-SCHEDULE NARCOTIC NO NEED PRESCRIPTION
TRAMADOL
321
DRUG WITH DIFFERENT CLASSIFICATION (OPIOID/NON-OPIOIDS)
TRAMADOL PROPOXYPHENE (DARVON) PENTAZOCAINE (TALWIN)
322
NARCOTICS (DEPRESSANT) THAT ARE METABOLIZED TO A CNS STIMULANT BY THE LIVER:
MEPERIDINE AND PROPOXYPHENE
323
COMPREHENSIVE DANGEROUS DRUG ACT OF 2002
RA 9165
324
GENERAL ACT OF 1988
RA 6678
325
POSSES THE HIGHEST POTENTIAL FOR USE DISORDER AND MISUES. NO MEDICAL USE
SCHEDULE I
326
REDUCED POTENTIAL FOR USE DISORDERS THAN SCHEDULE I. AT HIGH RISK FOR BOTH PHYSICAL & PSYCHOLOGICAL DEPENDENCE
SCHEDULE II
327
LOWER MISUES POTENTIAL THAN I AND II. MAY CAUSE PHYSICAL DEPENDENCE BUT MORE COMMONLY LEAD TO PSYCHOLOGICAL DEPENDENCE
SCHEDULE III
328
LIMITED RISK OF PHYSICAL OR PSYCHOLOGICAL DEPENDENCE
SCHEDULE IV
329
LEAST LIKELY OF THE CONTROLLED SUBSTANCES TO BE MISUSED. LIMITED PHYSICAL OR PSYCHOLOGICAL DEPENDENCE
SCHEDULE V
330
IMPAIRED CONTROL OVER TAKING THE DRUG
PHYSHIC DEPENDENCE
331
CONTINUED ADMINISTRATION OF THE DRUG IS REQUIRED TO PREVENT UNPLEASANT WITHDRAWAL SYNDROME
PHYSICAL DEPENDENCE
332
REPEATED EXPOSURE TO THE SAME DRUG DOSE LEADS TO DECREASE RESPONSE TO THE DRUG.
TOLERANCE
333
OPIOID WITHDRAWAL IS NOT LIFE THREATENING. TRUE OR FALSE?
TRUE
334
MOST COMMON DRUG ASSOCIATED WITH WITHDRAWAL SYMPTOMS (LIFE THREATENING)
ALCOHOL
335
SIMILAR TO TOLERANCE BUT MORE ACUTE
TACHYPHYLAXIS
336
TO INDUCE GENERAL ANESTHESIA ( MEDICALLY INDUCED REVERSIBLE COMA)
SEDATION AMNESIA MUSCLE PARALYSIS ANALGESIA
337
OVERDOSE OF ANESTHESIA CAN LEAD TO:
DEATH
338
INHALATIONAL DRUGS USED IN G.A
HALOTHENE (DESFLURANE)
339
SHORT ACTING HYPNOTIC AGENT
PROPOFOL
340
*ANALGESIC THAT BLOCK PAIN PRIMARILY IN THE PNS (CNS). *DOESN'T HAVE CNS DEPRESSANT EFFECT *DO NOT ACT ON OPIOID RECEPTORS
NON-NARCOTIC ANALGESIC
341
NON-NARCOTIC ANALGESIC DRUG
ACETAMINOPHEN ASPIRIN NSAIDS
342
MECHANISM ACTION OF NON-NARCOTIC ANALGESIC
DRUG INHIBIT THE ACTIVITY OF CYCLOOXYGENASE (CYCLOOXYGENASE INHIBITOR)
343
ENZYME IN OUR BODY RESULTING TO DEACREASE PROSTAGLANDIN PRODUCTION
CYCLOOXYGENASE
344
PROSTHAGLANDINS ARE PRODUCED IN:
CNS - ELEVATE CAUSES FEVER, HEADACHE,PAIN PNS -INCREASE PROSTHAGLANDIN CAUSES PAIN,INFLAMMATION,GASTRIC PROTECTION
345
GENERAL PHARMACOLOGICAL EFFECTS OF NON-NARCOTICS
MILD TO MODERATE PAIN CONTROLS FEVER/ ANTI-PYRETIC ANTI-INFLAMMATORY
346
BYPRODUCT OF CYCLOOXYGENASE PATHWAY
PROSTAGLANDIN THROMBOXANE A2 PROSTACYCLIN
347
ENZYME THAT BREAKDOWN PHOSPHOLIPID BILAYER DURING TISSUE DAMAGE
PHOSPHOLIPASE A2
348
BREAKDOWN OF PHOSPHOLIPID BILAYER BY PHOSPHOLIPASE A2 RESULT TO PRODUCTION OF ARACHIDONIC ACID
ARACHIDONIC ACID
349
ONCE ARACHIDONIC ACID ACID GOES TO THE RESPIRATORY SYSTEM. IT WILL BIND TO:
LIPOOXYGENASE
350
ARACHIDONIC ACID METABOLIZE BY LIPOOXYGENASE
LEUKOTRIENE
351
BINDING SITE OF LEUKOTRIENE
LEUKOTRIENE RECEPTOR
352
BINDING OF LEUKOTRIENE RECEPTOR IN LUNGS IT WILL RESULT TO:
BRONCHOCONSTRICTION
353
DRUG EXAMPLE OF LEUKOTRIENE RECEPTOR BLOCKER THAT PREVENT ASTHMA
MONTELUKAST
354
ENZYME IN CNS
COX 2
355
COX 2 IN CNS CONVERTS:
PROSTHAGLANDINS
356
PLATELET: BLOOD CLOTTING
THROMBOXANE A2
357
PROTECTS STOMACH/ INCREASE RENAL BLOOD FLOW
PROSTHAGLANDIN IN COX 2 CNS
358
COX 2 IN PNS CONVERTS INTO:
PROSTHAGLANDINS: PAIN, INFLAMMATION PROSTACYCLINS: INFLAMMTION, PAIN
359
CENTRALLY ACTING NON-NARCOTIC ANALGESIC
ACETAMINOPHEN
360
AKA PARACETAMOL / NO ANTI-INFLAMMATORY EFFECT.
ACETAMINOPHEN
361
EFFECTS OF ACETAMINOPHEN
ANTI-PYRETIC ANALGESIC NO GI IRRITATION NO ANTI-INFLAMMATORY EFFECT
362
PERIPHERALLY ACTING ANALGESIC (EXCEPT:ACETAMINOPHEN)
NON-NARCOTIC ANALGESIC
363
INHIBIT COX 1 & COX 2 IN PNS
NSAID
364
COMMON EFFECT OF NSAID
ANTI-INFLAMMATORY ANALGESIC ANTIPYRETIC ANTICOAGULANT GASTRIC IRRITATION GERD NAUSEA HEPATOTOXIC NEPHROTOXIC
365
THERAPEUTIC EFFECT OF NSAID
ANTI-INFLAMMATORY ANALGESIC
366
ASPIRIN + NSAID CAN ENHANCE THE EFFECTS OF:
WARFARIN (COUMADIN) AND COUMARIN
367
NSAID + ANOTHER NSAID CAN CAUSE:
EXACERBATE THEIR TOXIC EFFECT
368
NSAID + PARACETAMOL
SYNERGISTIC
369
DRUG EXAMPLE OF NSAID
IBUPROFEN DICLOFENAC PIROXICAM INDOMETHACIN SULINDAC NEBUMETONE
370
OTHER NSAID DRUG
MEFENAMIC DRUG TOLMETIN OXAPROZIN FLURBIPROFEN KETOPROFEN NAPHROXEN DIFLUNISAL ETOPOLAC ASPIRIN COX 2 INHIBITOR
371
ASPIRIN AKA:
ACETYLSALICYCLIC ACID
372
INACTIVE "PRODRUG" CONVERTED TO SALICYLATES
ASPIRIN
373
IT IRREVERSIBLY INHIBIT PLATELET COX 1
ASPIRIN
374
SIDE EFFECT OF ASPIRIN WHO CHILD HAD VIRAL INFECTION
REYES SYNDROME
375
SELECTIVELY INHIBIT COX 2
SELECTIVE COX 2 INHIBITOR
376
EFFECTS OF SELECTIVE COX 2 INHIBITOR
GASTRIC IRRITATION / GI IRRITATION INCREASE BLEEDING TENDENCY RENAL DAMAGE
377
COX 2 INHIBITOR DRUGS:
(-IB) ETORICOXIB CELECOXIB LUMIRACOXIB VALDECOXIB ROFECOXIB
378
DRUGS THAT NOT GIVE TO PATIENT PRIOR TO SURGERY
NSAID (ASPIRIN)
379
DRUGS THAT ARE HEPATOTOXIC
ACETAMINOPHEN, RIFAMPICIN,TETRACYCLINE
380
A TOXIC PRODRUG THAT IS CONVERTED TO ACETAMINOPHEN
PHENACETIN
381
EXCESSIVE DOSES OF THESE TWO DRUG CAN LEAD TO "NARCOTIC-LIKE" ADVERSE EFFECTS.
PENTAZOCINE PROPOXYPHENE
382
DRUG INTERACTION OF PNS ACTING AND CNS ACTING NON-NARCOTIC ANALGESIC
SYNERGISTIC
383
NON-SCHEDULE DRUG: DONT NEED PRESCRIPTION
TRAMADOL
384
BRAND NAME OF IBUPROFEN
ALAXAN MEDICOL MIDOL
385
GENERIC NAME OF FLANAX
NAPROXEN
386
TOXIC EFFECT OF COX 2 INHIBITOR
CAN LEAD TO HEART ATTACK OR STROKE OR ANY CARDIAL DISEASE
387
COX 2 INHIBITOR ARE TAKE MAXIMUM OF:
7DAYS
388
NSAID THAT REDUCE PAIN,FEVER,INFLAMMATION WITHOUT HAVING GI PROBLEMS
COX 2 INHIBITOR
389
ASSOCIATED WITH LIVER FUNCTION TEST ABNORMALITIES
DICLOFENAC AND SULINDAC
390
AN NSAID SAFE FOR PX AT HIGH RISK FOR GI BLEEDING AND NOT SAFE OF HIGH RISK FOR CARDIOVASCULAR TOXICITY
CELECOXIB
391
RECOMMENDED FOR PX WITH HIGH RISK FOR GI BLEEDING
CELECOXIB (OR A NON-SELECTIVE NSAID) + OMEPRAZOLE
392
RECOMMENDED DRUG FOR PX WITH RENAL INSUFFICIENCY-NONACETYLATED SALICYLATES
MAGNESIUM CHOLINE SALICYLATE SODIUM SALICYLATE SALICYL-SALICYLATE
393
OVERDOSE OF ASPIRIN
SALICYLISM
394
OLDEST NSAID
ASPIRIN
395
DRUG USE TO TREAT SALICYLISM
SODIUM BICARBONATE
396
TOXIC EFFECT OF ASPIRIN
GASTRIC IRRITATION RENAL DAMAGE
397
DRUG THAT ARE SIMILAR TO THE ENDOGENOUS GLUCOCORTICOIDS
SYNTHETIC GLUCOCORTICOIDS (CORTICOSTEROID DRUGS)
398
PRIMARY STRESS GREEN HORMONES
CORTISOL
399
DRUG WITH SUFFIX OF -SONE AND -LONE
STEROIDAL DRUGS
400
MECHANISM ACTION OF STEROID
INHIBIT THE PHOSPHOLIPASE A2 (ENZYME)
401
RESULT TO DECREASE ARACHIDONIC ACID
STEROIDAL DRUG
402
PHARMACOLOGICAL USES OF STEROIDS.
ANTI-INFLAMMATORY IMMUNOSUPPRESANT PREVENT GRAFT REJECTION AND PROSTHETIC REJECTION TX FOR ADDISON'S DISEASE
403
TREATMENT FOR ADDISON DISEASE
CORTICOSTEROIDS
404
WHEN ALLERGIC OCCUR AND ALLERGIC IN EPINEPHRINE DRUG BE GIVEN IS SEVERE ALLERGIES
STEROID OR CORTICOSTEROIDS
405
DRUG THAT CAN MASK INFECTION
CORTICOSTEROID
406
MAY CAUSE BONE RADIOLUCENCY
CORTICOSTEROID
407
RX APPEARANCE OF CORTICOSTEROID
BILATERAL MANDIBULAR RADIOLUCENCY
408
CHRONIC GLUCOCORTICOID INTAKE "LONG TERM" >2WEEKS MAY LEAD TO:
ADRENAL INSUFFICIENCY
409
WAITS FOR "ACH" COMING FROM ANTERIOR PITUITARY GLAND BEFORE SECRETING CORTISOL
ZONA FASCICULATA
410
RECEIVES "CRH" FROM HYPOTHALAMUS
ANTERIOR PITUITARY GLAND
411
COMES FROM BASOPHILES OF ANT. PITUITARY GLAND
ACTH
412
THE ONE CONTROL ANTERIOR PITUITARY GLAND
HYPOTHALAMUS
413
CONTROLS THE ZONA FASCICULATA
ANT. PITUITARY GLAND
414
SECRETES CORTISOL
ZONA FASCICULATA
415
HORMONE SECRETED BY HYPOTHALAMUS THAT CONTROL ANT.PITUITARY GLAND
CRH (CORTICOTROPHIC-RELEASING HORMONE)
416
STATE WHERE ADRENAL GLAND DO NOT SECRETE "ADEQUATE" GLUCOCORTICOID IN RESPONSE TO STRESS
ADRENAL INSUFFICIENCY
417
HIGH DOSE FOR MORE THAN 2WEEKS COMMONLY LEADS TO:
CUSHING'S SYNDROME
418
MOST PROBLEM OF PATIENT WITH ADDISON'S SYNDROME IS:
THEY CANNOT COPE UP WITH STRESSFUL SITUATION
419
RULE TO PREDNISONE (<40MG-LOW DOSE) * IF PX IS IN LOW DOSE (PREDNISONE) NO ANYSIGN OF ADRENAL INSUFFICIENCY
MAINTAIN THE DOSE
420
ANTIPSYCHOTIC DRUGS IS AKA:
MAJOR TRANQUILIZER NEUROLEPTIC AGENTS HALLUCINOGENS
421
DRUG THAT USED IN PATIENT WITH MENTAL DISORDER
ANTI-PSYCHOTIC DRUG
422
DRUG USED TO TREAT PSYCHOSES AND CAN AFFECT MOOD AND MENTAL PROCESS.
ANTI-PSYCHOTIC DRUG
423
CLASSIFICATION OF ANTIPSYCHOTIC (2)
TYPICAL ANTIPSYCHOTIC DRUGS ATYPICAL ANTIPSYCHOTIC DRUGS
424
ASSOCIATED WITH EXTRAPYRAMIDAL SYNDROME
TYPICAL ANTIPSYCHOTIC DRUGS (FIRST GENERATION)
425
COMMON SOURCE (1ST GEN ANTIPSYCHOTIC DRUG)
PHENOTHIAZINE DERIVATIVES THIOXANTHENE DERIVATIVES BUTYROPHENONE DERIVATIVES
426
PROTOTYPE OF 1ST GEN ANTIPSYCHOTIC
CHLORPROMAZINE
427
PROTOTYPE OF 2ND GEN
CLOZAPINE
428
NOT ASSOCIATED WITH EXTRAPYRAMIDAL SYNDROME
ATYPICAL ANTIPSYCHOTIC DRUGS (SECOND GEN)
429
COMMON ADVERSE EFFECT OF ANITPSYCHOTIC DRUGS
EXTRAPYRAMIDAL SYNDROME TARDIVE DYSKINESIA AKATHISIA PARKINSON'S SYNDROME / DISEASE ACUTE DYSTONIC REACTION
430
MOVEMENT DISORDER
EXTRAPYRAMIDAL SYNDROME
431
ABNORMAL INVOLUNTARY REPEATED BODY MOVEMENTS
TARDIVE DYSKINESIA
432
UNCONTROLLED RESTLESSNESS
AKATHISIA
433
ROLLING PIN / SLOW MOVEMENT, SHAKING, STIFFNESS, POSTURAL INSTABILITY REDUCED ARMSWING/ DEFICIENT DOPAMINE LEVELS
PARKINSON'S DISEASE PARKINSON'S SYNDROME
434
SPASTIC RETROCOLLIS OR TORTICOLLIS
ACUTE DYSTONIC REACTION
435
TYPES OF PSYCHOTIC DISORDER
SCHIZOPHRENIA MANIC-DEPRESSIVE SYNDROME
436
CAUSED BY EXCESSIVE DOPSMINE LEVEL/ MOST PROBLEM IS DELUSIONAL
SCHIZOPHRENIA
437
TX FOR SCHIZOPRENIA
ANTIPSYCHOTIC DRUG
438
AKA BIPOLAR DISORDER
MANIC-DEPRESSIVE SYNDROME
439
GREAT EXCITEMENT, EUPHORIA, EXCESSIVE OPTIMISM
MANIC
440
FEELING OF SADNESS OR LOSS OF INTEREST, ANXIETY, SLEEP DISTURBANCE & DIURNAL VISION
DEPRESSION
441
FIRST DRUG THAT BECAME EFFECTIVE FOR BIPOLAR DISORDER
LITHIUM ION
442
OTHER COMMON DRUGS USED IN ANTIPSYCHOTIC:
CARBAMAZEPINE AND VALPROIC ACID LAMOTRIGINE CHLORPROMAZINE ,OLANZAPINE, QUETIAPINE OLANZAPINE + FLUOXETIME QUETIAPINE
443
ADVERSE EFFECT (1ST GEN) ANTIPSYCHOTIC
EXTRAPYRAMIDAL SYNDROME TARDIVE DYSKINESIA PARKINSONISM LIKE SYMPTOMS
444
MOST COMMON TCA (TRICYCLIC ANTIDEPRESSANT) FOR DEPRESSION
AMITRIPTYLINE
445
PATIENT PRESENT WITH "TIC"
TOURETTE'S SYNDROME
446
HABITUAL SPASMODIC MUSCLE COMTRACTION / UTTERING WORDS
ANTIPSYCHOTIC DRUG
447
ANTIPSYCHOTIC DRUG WITH ANTIHYPERTENSIVE PROPERTIES.
RESERPINE
448
DRUG USED FOR NEUROLEPTIC ANALGESIA
NARCOTIC BUTYROPHENONES NITROUS OXIDE
449
NERVOUS DISORDER CAHRACTERIZED BY A STATE OF UNEASINESS AND APPREHENSION TYPICALLY WITH PANIC ATTACKS
ANXIETY
450
ANTI-ANXIETY DRUG
ANXIOLYTIC
451
DRUG THERAPY FOR ANXIETY
ANTI-ANXIETY (MINOR TRANQUILIZER) ANTI-DEPRESSANT
452
MOST COMMON ANTIANXIETY DRUG
DIAZEPAM
453
OTHER BENZODIAZEPINE USED FOR ANTIANXIETY
CHLORDIAZEPOXIDE CHLORAZEPATE DIAZEPAM
454
PRODUCES SEDATION AND RESPIRATORY DEPRESSION
"SNAB"
455
TYPE OF DEPRESSION DUE TO EXTERNAL STIMULI
EXOGENOUS DEPRESSION
456
TYPE OF DEPRESSION WHICH DOESN'T INVOVLE EXTERNAL STIMULI
ENDOGENOUS DEPRESSION
457
DRUGS ARE USED TO TREAT MAJOR DEPRESSIVE DISORDER
ANTIDEPRESSANT
458
CHARACTERIZED BY DEPRESSED MOOD MOST OF THE TIME FOR ATLEAST 2 WEEKS AND LOST OF INTEREST OR PLEASURE IN MOST ACTIVITIES
MAJOR DEPRESSIVE DISORDER
459
(2) HYPOTHESIS ACCEPTED FOR THE PATHOPHYSIOLOGY OF THE DISEASE
MONOAMINES HYPOTHESIS NEUROTROPIC HYPOTHESIS
460
MORE ACCEPTED HYPOTHESIS
MONOAMINE HYPOTHESIS
461
DEPRESSED PX HAVE DECREASE MONOAMINE NEUROTRANSMITTER IN THE CNS
MONOAMINE HYPOTHESIS
462
CONTROLS OF MOOD
DOPAMINE NOREPINEPHRINE SEROTONIN
463
DEPRESS PX HAVE DECREASE NERVE GROWTH FACTOR
NEUROTROPIC HYPOTHESIS
464
DRUG EXAMPLES OF ANTIDEPRESSANT
SSRI \SNRI TCA MAO INHIBITOR
465
INCREASE SEROTONIN IN SYNAPSE
SSRI
466
DRUG PREVENT THE REUPTAKE OF THE SEROTONIN AT THE AXON TERMINAL
SSRI
467
INCREASE SEROTONIN & NOREPINEHRINE IN SYNAPSE
SNRI
468
EXAMPLE DRUG OF SNRI
SNRI TRICYCLIC ANTIDEPRESSANT
469
COMMON TCA DRUG
AMITRIPTYLINE
470
TCA DRUGS:
IMAPRAMINE DESIPRAMINE AMITRIPTYLINE PROTRIPTYLINE DOXEPIN
471
DRUG INHIBITS THE MONOAMINES OXIDASE
MAO INHIBITORS
472
EXAMPLE DRUG OF MAO INHIBITOR
FLUOXETINE
473
MECHANISM ACTION OF ANTI DERPRESSANT
ELEVATES ADRENERGIC NEUROTRANSMITTER "EXCITATORY NEUROTRANSMITTER"
474
TX FOR DEPRESSION WHERE BRAIN IS STIMULATED USING ELECTRICITY
ELECTROSHOCK THERAPY
475
DRUG CONTRAINDICATED WITH MAO INHIBITOR AND WILL PPRODUCE HYPERPYREXIA
MEPERIDINE SSRI EPINEPHRINE EPHENDRINE
476
MOST COMMON ABUSED DRUG IN THE WORLD WIDELY USED BY MANKIND
ETHYL ALCOHOL (ETHANOL)
477
EFFECTS OF ALCOHOL
EUPHORIA ATAXIA INTOXICATION ACUTE CONSUMPTION
478
USED FOR ALCOHOLISM / USED FOR ALCOHOLIC PX AND THEY WANT TO WITHDRAW (ANTABUSE DRUG)
DISULFIRAM
479
ALCOHOL INHIBITS ___HORMONE RESULT TO INCREASE URINE OUTPUT
ANTI-DIURETIC HORMONE
480
ALCOHOL CAN CAUSE PERMANENT NERVE DAMAGE OR NECROSIS CAN SOMETIMES USED AS TX FOR DISEASE
TIC DOULOUREUX
481
DRUG ALTER THE AUTONOMIC NERVOUS SYSTEM
AUTONOMIC DRUG (ANS)
482
TWO MAIN BRANCHES AUTONOMIC N.S
PARASYMPATHETIC & SYMPATHETIC
483
RECEPTOR OF SYMPATHETIC NEURONS.
ADRENIERGIC RECEPTORS
484
A1 BLOOD VESSELS ONCE IT ACTIVATED WILL LEAD TO:
VASOCONSTRICTION
485
A2 FOUND BLOOD VESSELS BUT IT HAS OPPOSITE THAT CAUSE:
VASODILATION
486
B1 FOUND IN CARDIAC (MYOCYTE) ONCE IT ACTIVATED IT:
INCREASE FORCE OF CONTRACTION AND RATE OF CONTRACTION THAT CAUSE ARRHYTHMIA
487
B2 FOUND IN BRONCHIAL AIRWAY ONCE IT IS ACTIVATED: ALSO FOUND IN BLOOD VESSELS LEADING TO:
BRONCHODILATION VASODILATION
488
DRUG THAT DIRECTLY OR INDIRECTLY ACTIVATE THE ADRENERGIC RECEPTORS.
ADRENERGIC DRUG
489
CLASSIFICATION ACCORDING TO ACTION (ADRENERGIC RECEPTOR)
DIRECT ACTING INDIRECT ACTING
490
DIRECTLY STIMULATE ADRENERGIC RECEPTOR (ALPHA & BETA)
DIRECT ACTING
491
IS AN ALPHA 1, BETA 1 & 2 AGONIST
DOPAMINE
492
BETA 1&2 AGONIST/ GOOD FOR PX WITH ASTHMA
ISOPROTERENOL
493
MAINLY ALPHA 1&2 AGONIST / USED WHEN PX IS IN LOW BLOOD PRESSURE
NOREPINEPHRINE
494
NOREPINEPHRIN BINDS TO THESE RECEPTORS
ALPHA&BETA
495
MOST POTENT ALPHA AGONIST / GOOD FOR ANAPHYLACTIC SHOCK (1ST CHOICE FOR REVIVE)
EPINEPHRINE
496
USED FOR CASES THAT HAVE HYPOTENSION
PHENYLEPHRINE
497
SELECTIVE ALPHA 1 AGONIST
PHENYLEPHRINE
498
SELECTIVE APLHA 2 AGONIST (ANTI-HYPERTENSIVE DRUG)
CLONIDINE (CATAPRES) METHYLDOPA
499
SELECTIVE ALPHA 1 AND BETA 1 AGONIST
DOBUTAMINE
500
USED FOR PX HAVE CARDIAC FAILURE
SELECTIVE ALPHA 1 AND BETA 1 AGONIST (DOBUTAMINE)
501
SELECTIVE BETA 2 AGONIST
ALBUTEROL (SALBUTAMOL) -DOC FOR ASTHMA TERBUTALINE
502
STIMULATES RELEASE OF NOREPINEPHRIN FROM ADRENERGIC NEURON
INDIRECT ACTING
503
DRUG EXAMPLES OF INDIRECT ACTING
TYRAMINE MEPHENTERMINE AMPHETAMINE METHYLPHENIDATE
504
USED FOR ADHD, NARCOLEPSY
METHYLPHENIDATE
505
COMMON BRAND OF METHYLPHENIDATE
RITALIN
506
USED FOR DEPRESSION , OBESITY, ADHD, NARCOLEPSY, REFORMULATE OF AMPHETAMINE
METHAMPHETAMINE
507
USED FOR OBESITY
EPHEDRINE
508
ARE NOT BRONCHODILATOR AND CANNOT REVERSE ACUTE ASTHMA
ALPHA RECEPTOR AGONIST
509
IT CANNOT REVERSE THE LETHAL EFFECTS OF ANAPHYLACTIC SHOCK BECAUSE IT IS MAINLY ALPHA 1&2 AGONIST
NOREPINEPHRINE
510
DRUGS THAT ANTAGONIZE ADRENERGIC RECEPTOR/IT BLOCK THE RECEPTOR SITE. IT PREVENT THE ACTIVATION OF THE RECEPTORS.
ADRENERGIC RECEPTOR BLOCKER/ANTAGONIST
511
ANTI-ARRHYTHMIA & ANTI-HYPERCENTIVE
SELECTIVE BETA 2 ADRENERGIC BLOCKER
512
INTERFERES WITH THE RELEASE AND STORAGE OF NOPEINEPHRINE IN ADRENERGIC NEURONS.
ANDRENERGIC NEURON BLOCKERS
513
DRUG INCREASE THE BLOOD PRESSURE BEFORE DECREASING THE BLOOD PRESSURE OF PATIENT
ADRENERGIC NEURON BLOCKER
514
DRUG CAUSES REVERSAL OF SOME EFFECTS OF EPINEPHRINE
ALPHA BLOCKER
515
NOREPINEPHRINE BINDS TO THE RECEPTORS
ALPHA AND BETAM
516
MOST POTENT ALPHA AGONIST / GOOD FOR ANAPHYLACTIC SHOCK
EPINEPHRINE
517
THE MOST IMPORTANT DRUG OF ALL TIME
THE DRUG OF LOVE. ILOVEYOU BABYYYYY
518
USED FOR CASES THAT HAVE HYPERTENSION
PHENYLEPHRINE
519
ANTIHYPERTENSIVE DRUG
SELECTIVE ALPHA 2 AGONIST
520
USED FOR PATIENTS WITH CARDIAC FAILURE
SELECTIVE 1 AND BETA 1 AGONIST
521
STIMULATES OF NOREPINEPHRINE FROM ADRENERGIC NEURON
INDIRECT ACTING
522
USED FOR DEPRESSION, OBESITY, ADHD, NARCOLEPSY / REFORMULATE TO AMPHETAMINE
METHAMPHETAMINE (SHABU)
523
EXAMPLES OF ADRENERGIC RECEPTOR ANTAGONISTS
-NON-SELECTIVE ALPHA BLOCKERS (ALPHA 1 AND 2) -SELECTIVE ALPHA 1 -NON SELECTIVE BETA BLOCKER
524
NON-SELECTIVE BETA BLOCKERS / BETA 1 AND 2
ANTI-ARRYTHMIA ANTI-HYPERTENSIVE
525
NOT BRONCHODILATORS AND CANNOT REVERSE ACUTE ASTHMA
ALPHA-RECEPTOR AGONIST
526
IT CANNOT REVERSE THE LETHAL EFFECTS OF ANAPHYLACTIC SHOCK BECAUSE IT IS MAINLY ALPHA 1, 2 AGONIST
NOREPINEPHRINE
527
DRUGS THAT ANTAGONIZE ADRENERGIC RECEPTORS
ANDRENERGIC RECEPTOR ANTAGONISTS / BLOCKERS
528
DIVISION OF "ANS" REGULATED MAINLY BY NOREPINEPHRINE / FIGHT OR FLIGHT / STRESS AND MERGENCY SITUATION
SYMPATHETIC NERVOUS SYSTEM
529
NEURONS BEFORE THE BANGLION
PREGANGLIONIC
530
NEURONS AFTER THE GANGLION
POSTGANGLIONIC
531
NEURONS RELEASING ACH
CHLOINERGIC NEURONS
532
WHAT ARE COLINERGIC NEURONS
MOTOR NEURON IN NMJ ALL PREGANG NEURONS POSTGANG OR PARASYMPATHETIC POST GANG OF SWEAT GLANDS
533
SKELETAL MUSCLE, ALL POSTGANGLIONIC NEURONS, CHROMATIN CELLS
NICOTINIC RECEPTORS ARE FOUND
534
MUSCARINIC RECEPTORS ARE FOUND
ALL EFFECTOR ORGANS OF PARASYMPATHETIC (SWEAT GLANDS)
535
NEURONS RELEASING NOREPINEPHRINE
ADRENERGIC NEURONS
536
ADRENERGIC RECEPTORS ARE FOUND IN?
ALL EFFECTOR ORGANDS OF SYMPATHETIC
537
MOST NUMEROUS ADRENERGIC RECEPTOR SEEN IN THE BLOOD VESSELS
ALPHA 1
538
ACTIVATES ADRENERGIC RECEPTOR A1 / A2 AND B1 / B2 TYRAMINE & MEPHENTERMINE -
AMPHETAMINES
539
BRONCHODILATORES USED TO REVERSE (PROPANOLOL + ASTHMA)
THEOPHYLLINE & THEOBROMINE
540
CAUSES TRANSIENT HYPERTENSION THEN HYPOTENSION
RESERPINE
541
EXAMPLES OF ACETYLCHOLINE-LIKE DRUGS
BETHANECOL CHLORIDE CARBOCHOL PILOCARPINE MUSCALINIC NICOTINE